mitosane

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Cardiotoxicity 07/01/1989 - "The potential cardiotoxicity, nephrotoxicity, and pulmonary toxicity of several mitomycin (MMC) derivatives, BMY-25067 (N-7-[2-(4-nitrophenyldithio)ethyl]MMC), BMY-26107 (N-7-[2-(4-aminophenyldithio)ethyl]MMC), BMY-26605 (N-7 acetyl-MMC), BMY-25690 (7-N-(dimethylaminomethylene)-10-[1-morpholinomethyleneamino)carbo nyl- oxy]MMC), BMY-26646 (N-7-[2-(4-fluorophenyldithio)ethyl]MCC), and BMY-25551 (7-(2-hydroxyethyl)mitosane), were evaluated in rats. "
2.	Neoplasms (Cancer) 05/01/1992 - "Experimental tumor inhibitory and toxic properties of the mitomycin A analogue 7-(2-hydroxyethoxy) mitosane (BMY-25551)."

1.	Mitomycin (Mitomycin-C)
2.	7-(2-hydroxyethoxy)mitosane
3.	N- 7- (2- (nitrophenyldithio)ethyl)mitomycin C
4.	mitomycin A